Literature DB >> 1557228

Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis.

C Hamelmann1, B Foerster, G D Burchard, R D Horstmann.   

Abstract

The effect of nonimmune human serum on Entamoeba histolytica trophozoites was studied: (a) using whole serum in the presence of Ca and Mg ions allowing complement activation via both the alternative and classical pathways or in the presence of MgEGTA permitting alternative pathway activation only; (b) using different E. histolytica isolates; (c) varying serum and trophozoite concentrations and the time of incubation; and (d) using three different methods to quantify lysis, i.e., microscopic inspection, flow cytometry and 111In release. All three methods yielded similar results, with flow cytometry being most sensitive in identifying membrane damage and 111In release being most valid in determining cell death. Microscopic analysis was reliable only when a chamber was used to calculate the number of complement treated cells in relation to the initial cell count. E. histolytica isolates were classified into three groups according to their susceptibility to lysis by complement: (i) pathogenic isolates after long term cultivation in vitro were susceptible; (ii) pathogenic isolates after recent in vivo passage were less susceptible; and (iii) nonpathogenic isolates were nearly unaffected by exposure to the alternative pathway alone. The extent of lysis of the various isolates correlated with the degree of complement consumption in the serum samples, suggesting that unlysed isolates did not activate complement under the conditions employed. In general, lysis of susceptible trophozoites increased with the serum concentration and with the time of incubation. However, when the trophozoite concentration was 10(6)/ml or higher, lysis no longer reflected complement susceptibility because of exhaustion of the complement supply.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557228     DOI: 10.1111/j.1365-3024.1992.tb00003.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  The invasiveness of Entamoeba histolytica - a continuing enigma.

Authors:  J P Ackers
Journal:  Clin Mol Pathol       Date:  1996-08

2.  Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters.

Authors:  S Ankri; T Stolarsky; R Bracha; F Padilla-Vaca; D Mirelman
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Cysteine proteinases and the pathogenesis of amebiasis.

Authors:  X Que; S L Reed
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.

Authors:  J Schmitz; J P Zimmer; B Kluxen; S Aries; M Bögel; I Gigli; H Schmitz
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica.

Authors:  L L Braga; H Ninomiya; J J McCoy; S Eacker; T Wiedmer; C Pham; S Wood; P J Sims; W A Petri
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

6.  Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).

Authors:  C Hamelmann; B Urban; B Foerster; R D Horstmann
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Trophozoites of Entamoeba histolytica express a CD59-like molecule in human colon.

Authors:  J Ventura-Juárez; R Campos-Rodríguez; R A Jarillo-Luna; L Muñoz-Fernández; J A Escario-G-Trevijano; J Pérez-Serrano; J L Quintanar; E Salinas; F R Villalobos-Gómez
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

8.  Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.

Authors:  Xiangyang Min; Meng Feng; Yue Guan; Suqin Man; Yongfeng Fu; Xunjia Cheng; Hiroshi Tachibana
Journal:  PLoS Negl Trop Dis       Date:  2016-01-29

9.  Complement is a rat natural resistance factor to amoebic liver infection.

Authors:  Alfonso Olivos-García; Mario Nequiz; Scarlet Liceaga; Edith Mendoza; Porfirio Zúñiga; Azucena Cortes; Gabriel López-Velázquez; Sergio Enríquez-Flores; Emma Saavedra; Ruy Pérez-Tamayo
Journal:  Biosci Rep       Date:  2018-10-02       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.